---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-000603"
form_type: "8-K"
ticker: "NXTC"
cik: "0001661059"
company_name: "NextCure, Inc."
filed_at: "2025-02-03T23:59:59+00:00"
generated_at: "2026-05-27T03:59:53.386545+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# NextCure receives Nasdaq bid price deficiency notice; has until July 30, 2025 to regain compliance

## Summary
- Nasdaq notified NextCure that its closing bid price was below $1.00 for 30 consecutive business days.
- Company has 180-day grace period ending July 30, 2025 to meet the $1.00 minimum bid for 10 consecutive days.
- If not compliant, NextCure may seek an additional 180-day extension if it meets other listing standards.
- The company is evaluating options including a reverse stock split; delisting risk remains.
- No immediate effect on trading; stock continues trading on Nasdaq Global Select Market.

## SEC filing metadata
- accession: 0001558370-25-000603
- form_type: 8-K
- ticker: NXTC
- cik: 0001661059
- company_name: NextCure, Inc.
- filed_at: 2025-02-03T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1661059/000155837025000603/0001558370-25-000603-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1661059/000155837025000603/nxtc-20250131x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-000603
- JSON: https://secwatch.observer/filing/0001558370-25-000603.json
- Plain text: https://secwatch.observer/filing/0001558370-25-000603.txt

## Source-grounded claims
- claim_id: fc41cb8eff423af9e9ed0bbbb2f502468d3a17b1
  claim: NextCure, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).
  evidence_excerpt: January 31, 2025, NextCure, Inc. (the “Company”, “we”, “us”, or “our”) received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market, LLC (“Nasdaq”) notifying us that the cl
  evidence_url: https://www.sec.gov/Archives/edgar/data/1661059/000155837025000603/0001558370-25-000603-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.